Highest
FII Buying Stocks in India: Hidden Gems Backed by Foreign Investors
1. Shoora
Designs
CMP: ₹51 | FII Holding: 44.7% (up from 0%)
About the
Company
Shoora Designs is a young player in India’s
jewelry market, pivoting from textiles to focus on natural and lab-grown
diamonds since 2022. It’s a small-cap stock with big ambitions, carving a niche
in an industry traditionally dominated by giants.
Key
Business Segments
- Manufacturing
and trading natural and lab-grown diamonds
- Designing
diamond-studded jewelry
Clientele
Shoora caters to domestic jewelry retailers
and individual buyers, with an eye on export markets like the US and Middle
East, where lab-grown diamonds are gaining traction.
Global
Presence and Revenue Distribution
Currently India-centric, Shoora is in the
early stages of building export channels. Revenue details are sparse, but its
focus on lab-grown diamonds suggests a lean toward modern, cost-conscious
buyers globally.
Revenue
Split
Specific breakdowns aren’t public yet, but
lab-grown diamonds likely form the bulk of its revenue, given their rising
popularity and lower production costs compared to mined diamonds.
Future
Plans & Growth Potential
Shoora aims to scale production and tap into
the booming demand for sustainable jewelry. With lab-grown diamonds projected
to grow at a 9% CAGR globally through 2030, this stock could shine if it
executes well.
Strengths
and Challenges
Strengths: Low-cost, ethical diamond
production; agility as a small player.
Challenges: Brand recognition in a crowded market; supply chain risks
for lab-grown tech.
Competitor
Analysis
It’s up against heavyweights like Tanishq and
emerging lab-grown specialists like Lightbox. Shoora’s edge lies in its nimble
operations and cost advantage.
Why Invest?
A 44.7% FII stake from zero is a massive vote
of confidence. If you’re bullish on sustainable luxury, Shoora offers
early-mover potential in a niche market.
Conclusion
Shoora Designs is a speculative bet with high
reward potential. Its pivot to lab-grown diamonds aligns with global trends,
making it a stock to watch for patient investors.
2. MOS
Utility
CMP: ₹269 | FII Holding: 19.1% (up from
1.1%)
About the
Company
MOS Utility is a fintech gem offering payment
and utility services through an open API platform. Since 2009, it’s been
bridging digital gaps for small businesses across India.
Key
Business Segments
- Aadhaar-enabled
payment systems
- Utility
bill payments
- Travel
and e-commerce solutions
Clientele
With over 150,000 partners—think kirana
stores, recharge shops, and small eateries—MOS serves India’s grassroots
economy.
Global
Presence and Revenue Distribution
It’s predominantly India-focused, with no
significant international revenue yet. Future plans hint at cross-border
ambitions.
Revenue
Split
Exact figures aren’t disclosed, but financial
services (like payments) likely dominate, given India’s digital payment boom.
Future
Plans & Growth Potential
MOS is eyeing insurance, digital marketing,
and logistics via its subsidiary, MOS Logconnect. India’s fintech market could
hit $200 billion by 2030, and MOS is well-positioned to grab a slice.
Strengths
and Challenges
Strengths: Vast partner network;
diversified services.
Challenges: Regulatory hurdles; competition from bigger fintechs.
Competitor
Analysis
Paytm and PhonePe loom large, but MOS’s B2B2C
model targets underserved merchants, giving it a unique edge.
Why Invest?
The FII jump from 1.1% to 19.1% screams
optimism. MOS blends growth and stability in a sector that’s only getting
hotter.
Conclusion
MOS Utility is a fintech sleeper hit. If it scales its network and diversifies smartly, it could deliver outsized returns.
3.
Indiabulls Enterprises
CMP: ₹18 | FII Holding: 17.2% (up from
0.2%)
About the
Company
Indiabulls Enterprises is a diversified
small-cap spun off from the Indiabulls Group, dabbling in equipment leasing,
LED lighting, and pharma.
Key
Business Segments
- Infrastructure
equipment leasing
- LED
lighting solutions
- Pharmaceuticals
Clientele
Construction firms, healthcare providers, and
small businesses form its core customer base.
Global
Presence and Revenue Distribution
It’s mostly India-based, with limited global
exposure. Revenue leans heavily on domestic leasing and lighting sales.
Revenue
Split
No public split available, but leasing likely
leads, given its historical focus.
Future
Plans & Growth Potential
A merger with Yaari Digital and a pivot toward
pharma growth signal a restructuring play. India’s infra boom could juice its
leasing arm.
Strengths
and Challenges
Strengths: Diversified revenue; low
stock price offers entry.
Challenges: Debt legacy; execution risks in pharma.
Competitor
Analysis
It rivals Crompton Greaves in lighting and
smaller leasing firms, but its pharma push pits it against giants like Sun
Pharma.
Why Invest?
FIIs see value in its turnaround story. At
₹18, it’s a cheap bet on a diversified recovery.
Conclusion
Indiabulls Enterprises is a high-risk,
high-reward pick. If its restructuring clicks, it could surprise to the upside.
4. Lerthai
Finance
CMP: ₹599 | FII Holding: 16.1% (up from 0%)
About the
Company
Lerthai Finance (formerly Maral Finance)
focuses on financial services, with roots in lending and investment management.
Key
Business Segments
- Lending
and financing
- Investment
advisory
Clientele
SMEs and retail borrowers in India are its
bread and butter.
Global
Presence and Revenue Distribution
Purely domestic for now, with no global
revenue streams disclosed.
Revenue
Split
Details are thin, but lending likely drives
the lion’s share.
Future
Plans & Growth Potential
Lerthai aims to deepen its SME financing
footprint, a sector poised for growth as India’s economy formalizes.
Strengths
and Challenges
Strengths: High CMP reflects
confidence; SME focus aligns with policy support.
Challenges: Interest rate risks; limited scale.
Competitor
Analysis
It squares off with Bajaj Finance and smaller
NBFCs, relying on niche expertise.
Why Invest?
The 16.1% FII stake signals untapped potential
in a pricey stock with growth legs.
Conclusion
Lerthai Finance is a premium play for
believers in India’s SME boom. It’s not cheap, but the upside could justify the
tag.
5.
Continental Seeds
CMP: ₹31 | FII Holding: 13.4% (up from 0%)
About the
Company
Continental Seeds and Chemicals produces seeds
and agrochemicals, catering to India’s vast farming community.
Key
Business Segments
- Seed
production (vegetables, grains)
- Agrochemicals
Clientele
Farmers and agricultural distributors across
rural India.
Global
Presence and Revenue Distribution
India-centric, with minor exports to
neighboring countries.
Revenue
Split
Seeds likely dominate, though exact figures
aren’t public.
Future
Plans & Growth Potential
With India’s agri sector modernizing,
Continental plans to boost R&D for high-yield seeds. A solid monsoon could
turbocharge growth.
Strengths
and Challenges
Strengths: Low-cost entry; essential
sector.
Challenges: Weather dependency; regulatory scrutiny.
Competitor
Analysis
It competes with Kaveri Seeds and Monsanto
India, leaning on affordability.
Why Invest?
FIIs betting 13.4% see agri as a long-term
winner. At ₹31, it’s a bargain with fundamentals.
Conclusion
Continental Seeds is a grounded pick for agri
bulls. Its low price and FII backing make it intriguing.
6.
Sudarshan Pharma
CMP: ₹31 | FII Holding: 13.1% (up from
1.4%)
About the
Company
Sudarshan Pharma manufactures specialty
chemicals and APIs (active pharmaceutical ingredients) for the pharma industry.
Key
Business Segments
- Specialty
chemicals
- Pharma
intermediates
Clientele
Domestic and international drugmakers rely on
its supplies.
Global
Presence and Revenue Distribution
Exports form a chunk of revenue, with India as
the base.
Revenue
Split
APIs likely lead, though specifics aren’t
disclosed.
Future
Plans & Growth Potential
Sudarshan is expanding capacity to meet global
pharma demand, a sector growing at 8% CAGR.
Strengths
and Challenges
Strengths: Export exposure; pharma
tailwinds.
Challenges: Raw material costs; competition.
Competitor
Analysis
It faces off with Divi’s Labs and smaller
chemical firms, banking on cost efficiency.
Why Invest?
FIIs jumping from 1.4% to 13.1% hint at
breakout potential in a hot sector.
Conclusion
Sudarshan Pharma’s low price and export focus
make it a sleeper hit for pharma fans.
7.
Himatsingka Seide
CMP: ₹149 | FII Holding: 12.1% (up from
3.3%)
About the
Company
Himatsingka Seide is a textile veteran,
producing bedding, drapery, and upholstery fabrics since 1985.
Key
Business Segments
- Home
textiles (bedding, curtains)
- Apparel
fabrics
Clientele
Global retailers like Walmart and Bed Bath
& Beyond, plus Indian brands.
Global
Presence and Revenue Distribution
Exports account for over 70% of revenue, with
the US and Europe as key markets.
Revenue
Split
Home textiles dominate, with apparel as a
smaller slice.
Future
Plans & Growth Potential
Himatsingka is scaling US operations and
pushing premium brands, eyeing a $5 billion global home textile market.
Strengths
and Challenges
Strengths: Strong export base;
established clients.
Challenges: Currency risks; rising input costs.
Competitor
Analysis
It battles Welspun India and Trident,
leveraging quality and scale.
Why Invest?
FIIs doubling down from 3.3% to 12.1% reflect
trust in its export-led growth.
Conclusion
Himatsingka Seide blends stability and upside,
perfect for textile enthusiasts.
8. Ekansh
Concepts
CMP: ₹105 | FII Holding: 9.9% (up from
2.9%)
About the
Company
Ekansh Concepts specializes in infrastructure
and renewable energy projects, a small-cap with big dreams.
Key
Business Segments
- Infra
construction
- Solar
and renewable energy
Clientele
Government bodies and private developers in
India.
Global
Presence and Revenue Distribution
India-focused, with no notable global revenue
yet.
Revenue
Split
Infra likely leads, with renewables growing.
Future
Plans & Growth Potential
Ekansh is riding India’s renewable push,
aiming for solar capacity expansion as the sector booms.
Strengths
and Challenges
Strengths: Policy tailwinds; infra
demand.
Challenges: Project delays; funding needs.
Competitor
Analysis
It’s up against Tata Power and smaller infra
firms, focusing on execution.
Why Invest?
FIIs see green energy upside, making this a
timely pick at ₹105.
Conclusion
Ekansh Concepts offers exposure to India’s
infra and renewable surge—a solid long-term bet.
9. Moksh
Ornaments
CMP: ₹14 | FII Holding: 8.8% (up from 0%)
About the
Company
Moksh Ornaments crafts gold and silver
jewelry, targeting India’s wedding and festive markets.
Key
Business Segments
- Gold
jewelry
- Silver
ornaments
Clientele
Retailers and wholesalers in India’s jewelry
hubs.
Global
Presence and Revenue Distribution
Domestic-focused, with minimal exports.
Revenue
Split
Gold likely dominates, given its market
weight.
Future
Plans & Growth Potential
Moksh plans to expand its retail footprint and
ride India’s jewelry demand wave.
Strengths
and Challenges
Strengths: Low entry price; cultural
demand.
Challenges: Gold price volatility; competition.
Competitor
Analysis
It takes on Titan and PC Jeweller, relying on
affordability.
Why Invest?
FIIs jumping in at 8.8% signal a cheap gem
with growth potential.
Conclusion
Moksh Ornaments is a budget-friendly play on
India’s jewelry love affair.
10. Achyut
Healthcare
CMP: ₹3 | FII Holding: 8.2% (up from 0%)
About the
Company
Achyut Healthcare trades and manufactures
generic drugs, a micro-cap in India’s pharma space.
Key
Business Segments
- Generic
medicines
- Pharma
trading
Clientele
Hospitals, pharmacies, and distributors in
India.
Global
Presence and Revenue Distribution
India-only for now, with no export data.
Revenue
Split
Trading likely leads, specifics unavailable.
Future
Plans & Growth Potential
Achyut aims to scale generic production as
India’s healthcare spends rise.
Strengths
and Challenges
Strengths: Dirt-cheap price;
healthcare demand.
Challenges: Scale limitations; regulatory risks.
Competitor
Analysis
It’s a minnow versus Cipla or Dr. Reddy’s,
focusing on low-cost generics.
Why Invest?
At ₹3 with 8.2% FII backing, it’s a lottery
ticket with healthcare upside.
Conclusion
Achyut Healthcare is a high-risk micro-cap for
speculative investors.
11. Yasho
Industries
CMP: ₹1716 | FII Holding: 7.2% (up from
1.0%)
About the
Company
Yasho Industries produces specialty chemicals
for food, pharma, and industrial use.
Key
Business Segments
- Food
antioxidants
- Pharma
chemicals
- Industrial
additives
Clientele
Global and Indian firms in food, pharma, and
manufacturing.
Global
Presence and Revenue Distribution
Exports make up 60%+ of revenue, with Europe
and Asia as key markets.
Revenue
Split
Food and pharma chemicals likely lead, though
exact splits aren’t public.
Future
Plans & Growth Potential
Yasho is boosting capacity to meet export
demand, a $10 billion market by 2030.
Strengths
and Challenges
Strengths: Export strength; premium
pricing.
Challenges: Raw material costs; forex risks.
Competitor
Analysis
It rivals BASF India and Aarti Industries,
excelling in niche chemicals.
Why Invest?
FIIs upping stakes to 7.2% reflect
export-driven growth at a fair valuation.
Conclusion
Yasho Industries is a quality pick for
chemical sector fans.
12. Shri
Keshav Cement
CMP: ₹134 | FII Holding: 7.1% (up from
2.5%)
About the
Company
Shri Keshav Cement produces cement and runs
solar power plants, a small-cap in India’s building boom.
Key
Business Segments
- Cement
manufacturing
- Solar
energy
Clientele
Construction firms and infra projects in South
India.
Global
Presence and Revenue Distribution
India-only, with no exports.
Revenue
Split
Cement dominates; solar is a growing sideline.
Future
Plans & Growth Potential
It’s expanding cement capacity and solar
output, riding India’s infra wave.
Strengths
and Challenges
Strengths: Dual revenue; infra demand.
Challenges: Regional focus; competition.
Competitor
Analysis
It takes on UltraTech and regional players,
leaning on cost control.
Why Invest?
FIIs see value in its cement-solar combo at
₹134.
Conclusion
Shri Keshav Cement is a steady pick for infra
believers.
13. Global
Pet Industries
CMP: ₹110 | FII Holding: 6.8% (up from 0%)
About the
Company
Global Pet Industries makes PET bottle-making
machines, a niche in India’s packaging sector.
Key
Business Segments
- PET
blow molding machines
- Ancillary
equipment
Clientele
Beverage and pharma packaging firms in India
and abroad.
Global
Presence and Revenue Distribution
Exports contribute significantly, with Asia
and Africa as key markets.
Revenue
Split
Machines likely lead, specifics unavailable.
Future
Plans & Growth Potential
It’s scaling exports as PET packaging demand
surges globally.
Strengths
and Challenges
Strengths: Export growth; niche
market.
Challenges: Tech upgrades; competition.
Competitor
Analysis
It faces Sidel and local players, banking on
affordability.
Why Invest?
FIIs at 6.8% see a packaging play with legs.
Conclusion
Global Pet Industries is a small-cap with
export upside.
14. Midwest
Gold
CMP: ₹338 | FII Holding: 6.6% (up from 0%)
About the
Company
Midwest Gold deals in granite and marble, a
small-cap tied to India’s real estate boom.
Key
Business Segments
- Granite
processing
- Marble
trading
Clientele
Builders and exporters in India.
Global
Presence and Revenue Distribution
Minor exports, mostly domestic-focused.
Revenue
Split
Granite likely leads, details scarce.
Future
Plans & Growth Potential
It’s eyeing export growth as India’s realty
sector heats up.
Strengths
and Challenges
Strengths: Realty tailwinds; fair CMP.
Challenges: Export scale; competition.
Competitor
Analysis
It’s up against Pokarna and smaller granite
firms.
Why Invest?
FIIs at 6.6% bet on real estate demand.
Conclusion
Midwest Gold offers a solid entry into India’s
stone market.
15. Avro
India
CMP: ₹141 | FII Holding: 6.1% (up from
0.1%)
About the
Company
Avro India manufactures plastic molded
furniture, a small-cap in a growing consumer space.
Key
Business Segments
- Plastic
furniture (chairs, tables)
- Storage
solutions
Clientele
Retailers and households across India.
Global
Presence and Revenue Distribution
India-focused, with export plans brewing.
Revenue
Split
Furniture dominates; specifics unavailable.
Future
Plans & Growth Potential
Avro aims to expand capacity and tap rural
demand as India’s furniture market grows.
Strengths
and Challenges
Strengths: Low-cost products; consumer
demand.
Challenges: Brand building; competition.
Competitor
Analysis
It rivals Nilkamal, leaning on affordability.
Why Invest?
FIIs upping stakes to 6.1% see a consumer play
with room to grow.
Conclusion
Avro India is a budget-friendly bet on India’s
furniture boom.
Final
Thoughts
These 15 stocks showcase the diversity of India’s small and mid-cap universe—from diamonds to fintech, cement to furniture. FIIs piling in signal confidence in their growth stories, but risks like competition, scale, and execution remain. For retail investors, these hidden gems offer a mix of value and speculation. Do your homework, weigh the risks, and consider jumping in where the smart money’s already betting big. Happy investing!
Read More Article : Best Stocks To Buy In Summer India | Top 50+ Stocks to Watch
Conclusion
India’s stock market is buzzing with potential, and these top FII holdings India stocks are proof. From Shoora Designs’ sustainable edge to Yasho Industries’ chemical strength, FII buying stocks India spotlight a range of hidden gems stock market enthusiasts can’t ignore. Foreign investors India stocks are pouring capital into these best small-cap stocks 2025, betting on their growth across fintech, pharma, and more. For retail investors, it’s a golden window to jump in early—though risks like competition and execution loom large. Research thoroughly, weigh your options, and you could strike gold with these picks.
Please note: This article is for educational purposes only and not investment advice. The smart money’s here—will you join the ride?
0 Comments